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Background: The removal of mercury sphygmomanometers from health centers requires the validation of other
instruments to measure blood pressure in the limbs to calculate the ankle-brachial index (ABI).
Methods: Descriptive cross-sectional study of agreement between two measurement methods in type 2 diabetes
patients from three urban primary healthcare centres in the Barcelonès Nord i Maresme area (Catalonia, Spain).
ABI was determined with Doppler and mercury sphygmomanometer and Doppler and the “hybrid”
sphygmomanometer OMRON HEM-907 model. Agreement was evaluated using the weighted kappa index.
Sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) were calculated using the
mercury sphygmomanometer as the gold standard.
Results: 211 patients were included, from these, 421 limbs were available for study. The mean age of the
participants was 67 years (SD = 10), 51.7% were women.
The index of agreement between ABI measured with a mercury sphygmomanometer and with the OMRON HEM-
907 blood pressure monitor was good (weighted kappa index = 0.68; CI 95%: [0.55–0.79]) and improved when the
ABI cut-off value was set at ≤0.70 (weighted kappa index = 0.92; CI 95%: [0.81–1.00]). Sensitivity and specificity were
77.5% and 98.2%, respectively. PPV was 83.8% and NPV was 97.3%. With the ABI cut-off value ≤0.70, sensitivity and
specificity increased to 85.7% and 100%, respectively, PPV to 100% and NPV to 99.4%.
Conclusion: The combination of a Doppler device with the hybrid sphygmomanometer is a simple and reliable
method to measure ABI showing that hybrid sphygmomanometer is a good alternative to the use of mercury
sphygmomanometers.
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Peripheral arterial disease (PAD), a clinical manifestation
of arteriosclerosis, is associated with increased cardio-
vascular risk [1,2]. Early detection of PAD, preferably in
the pre-clinical stages, is essential to prevent the compli-
cations associated with this condition. The ankle-
brachial index (ABI) is a simple and non-expensive
method to diagnose PAD compared with angiography* Correspondence: mbundo.bnm.ics@gencat.cat
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reproduction in any medium, provided the or[3] with high sensitivity and specificity. ABI is calculated
by dividing the higher systolic blood pressure (SBP)
measured in the ankle by the higher brachial SBP [1].
Many studies have shown the value of ABI as a diagnos-
tic tool for PAD and as an indicator of cardiovascular
risk [4,5].
The removal of mercury sphygmomanometers from
health care centres based on environmental grounds [6]
has prompted to search alternative reliable instruments
to measure blood pressure (BP) [7]. Aneroid sphygmo-
manometers use the auscultatory technique and theirLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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other. Also, they require frequent calibration [8].
Oscillometric sphygmomanometers use oscillometric
measurements and electronic calculation rather than
auscultation. They are validated to determine BP in the
arm but there are some limitations in cases of arterial
calcification as in the elderly and diabetic patients [8].
To determine ABI, studies have initially excluded pa-
tients with arterial calcification in lower limbs otherwise
have obtained low sensitivity results [9-12].
Hybrid sphygmomanometers combine features of both
electronic and auscultatory devices [8]. The mercury
manometer is replaced by a digital display similar to the
oscillometric devices. Systolic and diastolic blood pres-
sures are identified by the Korotkoff sounds of the aus-
cultatory technique. These sphygmomanometers have
shown efficacy to determine BP and could be the best
choice compared to the mercury ones [13,14]. HEM-907
is a model manufactured by OMRON. It performs as a
hybrid sphygmomanometer in the manual position and
the pressure applied to the limb is continuously indi-
cated. This monitor has been validated for BP measure-
ment in the arm [15], but the applicability of hybrid
sphygmomanometers in BP measurement in the lower
limbs has not been established.Objective
The aim of this study is to determine the agreement be-
tween the ABI measured with Doppler and mercury
sphygmomanometer and the ABI measured with Doppler
and the OMRON HEM-907 hybrid sphygmomanometer.Methods
The study took place in three urban Primary Health
Care centres in the Barcelonès Nord and Maresme area
(Catalonia, Spain) from June to September 2008.
Patients aged 50 or over with type 2 diabetes mellitus
were included in the study. The study was approved by
the Ethics Committee and all patients signed the consent
form. The exclusion criteria were cardiac arrhythmia, a
history of PAD surgery, ankle circumference over 40 cm
and refusal to sign the informed consent form.
The rationale for the selection of type 2 diabetic pa-
tients was their high prevalence of PAD and stiffness of
the arteries associated with extreme ABI values [16].
The OMRON HEM-907 hybrid sphygmomanometer
determines BP through oscilometric or auscultatory
methods according to the choice of the evaluator. For de
manual auscultatory BP measurement the cuff inflates
automatically and deflates slowly. The pressure applied
to the limb is continuously indicated and using the
Doppler is possible to determine the SBP through
auscultation.The participants were examined in a relaxed atmos-
phere with a pleasant temperature. After 10 minute rest
in supine position, SBP in the brachial artery was mea-
sured in both arms. SBP in the left and right posterior
tibial and dorsalis pedis arteries was measured with the
cuff placed proximal to the malleoli and the contour ad-
justed to the conical shape of the lower leg [17].
An 8-mHz Doppler device (Dopplex HNE) was used
either with a mercury sphygmomanometer or the
OMRON HEM-907 hybrid sphygmomanometer in the
manual position. Pulse was located with the Doppler
vascular probe and the cuff inflated to restrict blood
flow. The examiner slowly released the pressure in the
cuff to determine at what pressure blood flow was just
starting, and at what pressure it was unimpeded.
In the ankle the SBP was initially measured at the
dorsalis pedis pulse following the posterior tibial. If the
difference was higher than 10 mmHg a new measurement
was done. The new values were recorded if the difference
was lower than 10 mmHg. If the difference of 10 mmHg
continued a third measurement was done and recorded.
The time between measurements was 3 minutes.
These measurements were carried out by two expert
health workers especially trained for this study.
Firstly, one of the professionals made the measure-
ments with one of the BP monitors randomly selected.
Afterwards, a different healthcare professional blinded to
the values obtained in the first examination carried out
the measurements in the same patient with the other
type of sphygmomanometer. The ABI of each leg was
calculated separately by dividing the higher of the two
ankle systolic pressures in that leg by the higher brachial
systolic pressure value.
The two lower limbs of each patient were considered
independent. Therefore, each patient had two posterior
tibial and two dorsalis pedis BP measurements and an
ABI for each leg was calculated. An ABI ≤ 0.90 was con-
sidered abnormal, whereas a value ≥ 1.40 suggested ar-
terial calcification [1].
Other variables obtained during this visit were age,
sex, history of arterial hypertension, weight, height, body
mass index (BMI) and arm and ankle circumference.Analysis
Sample size was calculated to detect a significant kappa
index of 0.25 with a bilateral alpha risk of 0.05. The esti-
mated proportion of an abnormal ABI (≤ 0.90) in the
diabetic population was 15.6%, of a normal ABI (0.91–
1.39) 77% and for ABI values suggestive of calcified ar-
teries (≥ 1.40) 7.4%.
Therefore, a sample size of 200 patients allowed to
detect significant differences in the brachial SBP of
2 mmHg with a SD of 10 mmHg (α = 0.05 and β = 0.20).
Table 1 Characteristics of the patients studied
Characteristics Patients (n = 211)




Weight (Kg), mean (SD) 77 (14)
Height (cm), mean (SD) 159 (10)
BMI (Kg/m2), mean (SD) 30.3 (5.2)
Normal (20–25), n (%) 41 (19.9)
Overweight (26–30), n (%) 67 (32.5)
Obese (>30), n (%) 98 (47.6)
History of hypertension, n (%) 149 (74.1)
Upper arm circumference (cm), mean (SD) 29 (3)
> 32 cm, n (%) 24 (12.1)
Ankle circumference 1 (cm), mean (SD) 25 (4)
> 32 cm, n (%) 7 (3.5)
SD: Standard Deviation; BMI: Body Mass Index.
Table 2 Systolic blood pressure and ankle-brachial index




Brachial SBP (mmHg), mean (SD) 140 (17) 140 (17)
Dorsalis pedis SBP (mmHg), mean (SD) 158 (30) 157 (30)
Posterior tibial SBP (mmHg), mean (SD) 160 (31) 160 (30)
ABI, n (%)
Normal (0.91–1.39) 340 (80.8) 344 (81.7)
Abnormal (≤ 0.90) 40 (9.5) 37 (8.8)
Calcification (≥ 1.40) 41 (9.7) 40 (9.5)
Abnormal (≤ 0.70) 14 (3.3) 12 (2.8)
SD: Standard Deviation; SBP: Systolic Blood Pressure; ABI: Ankle-Brachial Index.
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Intraclass Correlation Coefficient (ICC) was used to
evaluate the agreement between the brachial SBP values
determined with Doppler and mercury sphygmomanom-
eter and with Doppler and the OMRON monitor.
The scale applied to evaluate the degree of agreement
with this coefficient was as follows: <0.10 null agree-
ment, from 0.10 to 0.30 bad agreement, from 0.31 to
0.50 poor agreement, from 0.51 to 0.70 moderate, from
0.71 to 0.90 good and > 0.90 very good agreement. Simi-
larly, the ICC was used to evaluate the agreement be-
tween lower limb SBP measurements done with the
mercury sphygmomanometer and the OMRON device
and between the individual values of ABI determined
with both methods.
The weighted kappa index (k) was used to evaluate the
agreement between the qualitative ABI values deter-
mined with both methods. In this case, the scale used to
assess the degree of agreement was: k ≤ 0.20 poor, k from
0.21 to 0.40 weak, from 0.41 to 0.60 moderate, from 0.61
to 0.80 good and k from 0.81 to 1 very good.
Sensitivity, specificity, positive predictive value (PPV),
negative predictive value (NPV), positive likelihood ratio
and negative likelihood ratio of the OMRON equipment
to detect an abnormal ABI (≤0.90) were calculated with
the standard formulae.
The differences between the mercury sphygmoman-
ometer and the OMRON monitor for ABI quantitative
values are shown in the Bland and Altman plot. The
mercury sphygmomanometer was considered to be the
gold standard. All analyses were performed using Stata/
SE Version 11 (StataCorp, Collage Station, TX, USA).
Results
General data
The study included 211 patients with type 2 diabetes.
The two lower limbs of each patient were considered in-
dependent, thus a total of 421 measurements (one pa-
tient had a metatarsal amputation) were carried out.
Patient description is shown in Table 1. The mean age
of the participants was 67 years (SD = 10), 51.7% were
women and 47.6% (98) had a BMI > 30 Kg/m2. Diagnosis
of arterial hypertension was reported in 74.1% (149) of pa-
tients, 17.1% were smokers and the mean time to diagnose
diabetes was 7.1 years (SD = 4,4). Four patients were ex-
cluded because of an ankle circumference > 40 cm, they
were men, obese and hypertensive, with an average age of
56 years (SD = 5.8).
Systolic Blood Pressure (SBP) and Ankle-Brachial Index
(ABI)
Table 2 shows the mean values of brachial and ankle
SBP and ABI values obtained with the mercury sphyg-
momanometer and the OMRON HEM-907 monitor.According to the mercury sphygmomanometer abnormal
ABI was observed in 40 limbs (9.5%) and 41 (9.7%) were
suggestive of calcification. More men than women
obtained abnormal ABI values (17.7% vs. 1.8%; p < 0.001).Agreement on SBP between the mercury
sphygmomanometer and the OMRON HEM-907 BP
monitor
A very good agreement was found between brachial SBP
measured with a mercury sphygmomanometer and bra-
chial SBP measured with the OMRON HEM-907 moni-
tor (ICC = 0.91; CI 95%: [0.87; 0.93]). Similar positive
results were found when measuring SBP in the ankle
(dorsalis pedis SBP: ICC = 0.85; CI 95%: [0.79; 0.89] and
posterior tibial SBP: ICC = 0.89; CI 95%: [0.87; 0.91]).
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0.08 mmHg (SD = 7.4) for brachial SBP. The mean differ-
ences in ankle SBP measurements were 0 mmHg (SD =
16.5) in the dorsalis pedis SBP and -0.28 mmHg (SD =
14.4) for the posterior tibial SBP.
The differences between both techniques were correlated
throughout the range of ankle SBP measurements. The rise
in SBP did not increase these differences. In the case of the
dorsalis pedis SBP, 95% of the differences observed
concerning the two techniques were between -33.10 mmHg
and 33.10 mmHg. For the posterior tibial artery SBP
95% of the differences were between -29.02 mmHg and
28.46 mmHg (Figure 1).
Brachial SBP differences were also correlated through-
out SBP values and 95% of the differences in measure-
ments with the mercury sphygmomanometer compared
with the OMRON HEM-907 monitor ranged between -
14.79 mmHg and 14.95 mmHg (Figure 2).Agreement on ABI between the mercury
sphygmomanometer and the OMRON HEM-907 BP
monitor
From the 40 limbs with an abnormal ABI measured with
the mercury sphygmomanometer, 9 (22.5%) obtained a
normal value with the OMRON monitor and none
presented values of calcification (Figure 3). On the other
hand, six measurements carried out in lower limbs had
criteria of PAD and 11 of calcification with the OMRON
device and obtained normal values with the mercury
sphygmomanometer. Therefore, 5% of the lower limbs
considered normal by the mercury sphygmomanometer
were abnormal or calcified according to the OMRON
monitor. Modifying the cut off value for the ABI to
≤ 0.70 [18], the OMRON sphygmomanometer only
missed diagnosis of PAD in two legs.Figure 1 Bland & Altman graphic: differences between mercury sphyg
blood pressure.The agreement between ABI values measured with the
mercury and the OMRON sphygmomanometers was
good (weighted k =0.68; CI 95%: [0.55; 0.79]) (Table 3).
Sensitivity and specificity were 77.5% and 98.2%, re-
spectively, with a PPV of 83.8% and a NPV of 97.3%. The
agreement increased with ABI cut-off ≤ 0.70 (weighted k =
0.92; CI 95%: [0.81; 1.00]). This cut-off improved also sen-
sitivity and specificity to 85.7% and 100%, respectively, as
well as the PPV and NPV that reached 100% and 99.4%,
respectively.
The Bland and Altman graph (Figure 4) showed that
the differences between the two techniques were
constant for the whole range of ABI values and these
differences did not change increasing the ABI value.
Ninety-five percent of the differences in ABI observed
between the two techniques were between -0.223 mmHg
and 0.227 mmHg corresponding to the interval repre-
sented in Figure 4. In addition, a good agreement was
found between individual values of ABI measured with a
mercury sphygmomanometer and with the OMRON
HEM-907 monitor (ICC = 0.86; CI 95%: [0.81; 0.90]).
Discussion
The results of this study show good agreement between
ABI values obtained with the mercury sphygmomanom-
eter compared to those measured with the OMRON BP
monitor. The sensitivity and specificity of the ABI mea-
sured with the OMRON HEM-907 sphygmomanometer
were 77.5% and 98.2%, respectively with a PPV of 83.8%
and a NPV of 97.3%.
When the cut-off value is defined to ≤ 0,70 sensitivity
and specificity improve to 85.7% and 100% respectively.
Moreover PPV and NPV reach 100% and 99.4%. Only in
two of 14 lower limbs with ABI ≤ 0.70 measured with the
mercury sphygmomanometer did the OMRON monitor
obtain normal ABI values. That could be explained by themomanometer and OMRON HEM-907 device for ankle systolic
Figure 2 Bland & Altman graphics: differences between mercury sphygmomanometer and OMRON HEM-907 device for brachial
systolic blood pressure.
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lower are the ABI values obtained [19].
Leng et al. [18] did a study with 1592 patients and ob-
served that the ones that presented at baseline ABI ≤ 0,90
showed moderate specificity (83,2%), and a likelihood ratio
of 1.76 in predicting fatal and non-fatal cardiovascular
events after five years. However a lower index (ABI ≤ 0,70)
showed also better specificity (95.4%) and a higher likeli-
hood ratio (3.07).
Differences were observed between SBP measured
with Doppler and the OMRON BP monitor and SBP
obtained with Doppler and the mercury sphygmoman-
ometer, particularly in the lower limbs. Arterial stiffness
is more prevalent in the arteries of the lower limbs, par-
ticularly in diabetic and elderly patients, which may ac-
count for the distortion of SBP values and the better
correlation between the two methods found in the upper
limbs [20].Figure 3 Ankle-brachial index (ABI) measured with the mercury and tThis special feature of the lower limbs makes difficult
to find an appropriate instrument to replace the mercury
sphygmomanometers to measure ABI. The mercury
sphygmomanometer is considered to be the gold stand-
ard but its removal based on environmental reasons
makes necessary to find an equivalent replacement.
Similarly to the mercury BP monitors, aneroid sphyg-
momanometers use auscultation of Korotkoff sounds to
determine SBP. However, the need for frequent calibra-
tion and the possibility of undetected failures render an-
eroid sphygmomanometers unreliable [21,22].
Kollias et al. [12] performed a study with 94 patients and
found a strong correlation between ocillometric and Dop-
pler ABI (r 0,80). However patients with arterial calcification
diagnosed by Doppler were excluded from the beginning.
In several publications oscillometric sphygmomanom-
eters have shown very low sensitivity in ABI measure-
ments [9-11]. Metanalisis [23] of studies that comparehe electronic device sphygmomanometers.
Table 3 Indices that assess the quality of the diagnostic
test
Weighted* Kappa (95% CI)
ABI ≤ 0.90 0.68 (0.55–0.79)
ABI ≤ 0.70 0.92 (0.81–1.00)
Sensitivity (95% CI)
ABI ≤ 0.90 77.5% (61.5–89.2)
ABI ≤ 0.70 85.7% (57.2–98.2)
Specificity (95% CI)
ABI ≤ 0.90 98.2% (96.1–99.3)
ABI ≤ 0.70 100% (99.0–100)
PPV (95% CI)
ABI ≤ 0.90 83.8% (68.0–93.8)
ABI ≤ 0.70 100% (73.5–100)
NPV (95% CI)
ABI ≤ 0.90 97.3% (94.9–98.8)
ABI ≤ 0.70 99.4% (98.0–99.9)
Positive Likelihood ratio
ABI ≤ 0.90 42.5 (18.9–95.5)
Negative Likelihood ratio
ABI ≤ 0.90 0.3 (0.1–0.4)
BP measurement using the mercury sphygmomanometer was considered the
reference method.
ABI: Ankle-Brachial Index; PPV: Positive Predictive Value; NPV: Negative
Predictive Value.
*Quadratics weights.
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the conventional doppler method attain sensibility of 69 ±
6% and specificity of 96 ± 1% to diagnose PAD. But these
studies present great heterogeneity both with the devices
and the methodology.Figure 4 Bland & Altman graphics: differences between individual va
device sphygmomanometers.In the automated oscillometric devices systolic and
diastolic blood pressure is indirectly calculated with an
algorithm that can be affected by factors other than
blood pressure, mainly arterial stiffness [8]. Arterial cal-
cification increases with age and diseases such as dia-
betes mellitus. PAD is highly prevalent in diabetes
patients [1,2] and therefore it is important to determine
a reliable ABI. This is a great inconvenience because
there are automated devices in the market very comfort-
able and fast to determine blood pressure in the arms
and ankles which could be very useful in clinical prac-
tice. Hybrid sphygmomanometers combine the advan-
tages of auscultatory and automated BP monitors.
Although the technique is more complicated than the
automated ones, they reduce the possibility of error by
automatically inflating and deflating the cuff and facili-
tating the measurements.
A limitation of this study is the type of patients se-
lected. The chances of error increase in a sample of eld-
erly diabetic patients with an obesity rate of 47.6%
[24,25]. However, it has also been an opportunity to test
these two methods in more challenging conditions than
the everyday clinical practice.Conclusions
The results of the current study show that ABI mea-
surements using a hybrid OMRON device are compar-
able to those obtained with the classical mercury
sphygmomanometer. As recommended for mercury
sphygmomanometers, BP measurements with hybrid
monitors should be repeated in patients with ABI
values around 0.90 [19], and particularly in patients
with ABI values ≥ 0.70.lues of ABI measured with the mercury and the electronic
Bundó et al. BMC Cardiovascular Disorders 2013, 13:15 Page 7 of 7
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907 BP monitor as the replacement of mercury sphyg-
momanometers in ABI measurement.
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